Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs
Open Access
- 21 February 2019
- journal article
- research article
- Published by Wiley in European journal of pain
- Vol. 23 (6) , 1129-1140
Abstract
Background: Although reproducibility is considered essential for any method used in scientific research, it is investigated only rarely; thus, strikingly little has been published regarding the reproducibility of evoked pain models involving human subjects. Here, we studied the reproducibility of a battery of evoked pain models for demonstrating the analgesic effects of two analgesic compounds.Methods: A total of 81 healthy subjects participated in four studies involving a battery of evoked pain tests in which mechanical, thermal and electrical stimuli were used to measure pain detection and tolerance thresholds. Pharmacodynamic outcome variables were analysed using a mixed model analysis of variance, and a coefficient of variation was calculated by dividing the standard deviation by the least squares means.Results: A total of 76 subjects completed the studies. After being administered pregabalin, the subjects’ pain tolerance thresholds in the cold pressor and pressure stimulation tests were significantly increased compared to the placebo group. Moreover, the heat pain detection threshold in UVB‐irradiated skin was significantly increased in subjects who were administered ibuprofen compared to the placebo group. Variation among all evoked pain tests ranged from 2.2% to 30.6%.Conclusions: Four studies using a similar design showed reproducibility with respect to the included evoked pain models. The relatively high consistency and reproducibility of two analgesics at doses known to be effective in treating clinically relevant pain supports the validity of using this pain test battery to investigate the analgesic activity and determine the active dosage of putative analgesic compounds in early clinical development.Significance: The consistency and reproducibility of measuring the profile of an analgesic at clinically relevant doses illustrates that this pain test battery is a valid tool for demonstrating the analgesic activity of a test compound and for determining the optimal active dose in early clinical drug development.Keywords
Funding Information
- Pfizer
This publication has 67 references indexed in Scilit:
- Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical researchBritish Journal of Pharmacology, 2013
- Human Experimental Pain Models for Assessing the Therapeutic Efficacy of Analgesic DrugsPharmacological Reviews, 2012
- Test–retest reliability of Quantitative Sensory Testing in knee osteoarthritis and healthy participantsOsteoarthritis and Cartilage, 2011
- Stability of behavioral estimates of activity-dependent modulation of painJournal of Pain Research, 2011
- Reliability of thermal quantitative sensory testing of the hand in a cohort of young, healthy adultsMuscle & Nerve, 2011
- Test–retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): A multi-centre studyPain, 2011
- Assessing efficacy of non‐opioid analgesics in experimental pain models in healthy volunteers: an updated reviewBritish Journal of Clinical Pharmacology, 2009
- Multi‐Modal and Tissue‐Differentiated Experimental Pain Assessment: Reproducibility of a New Concept for Assessment of AnalgesicsBasic & Clinical Pharmacology & Toxicology, 2006
- Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled StudyEpilepsia, 2005
- An Experimental Pain Model Based on Electric Stimulations of the Colon MucosaScandinavian Journal of Gastroenterology, 1999